News on Medial

Related News

RAS Luxury Skincare raises $7.5 Mn in Series B led by Dabur Ventures

EntrackrEntrackr · 16d ago
RAS Luxury Skincare raises $7.5 Mn in Series B led by Dabur Ventures
Medial

Snippets RAS Luxury Skincare raises $7.5 Mn in Series B led by Dabur Ventures Skincare brand RAS Luxury Skincare has raised $7.5 million in a Series B funding round led by Dabur Ventures, with participation from Unilever Ventures. The Raipur-based company had previously raised over $6.5 million. Skincare brand RAS Luxury Skincare has raised $7.5 million in a Series B funding round led by Dabur Ventures, with participation from Unilever Ventures. The Raipur-based company had previously raised over $6.5 million in funding, including a Series A round led by Unilever Ventures. The proceeds will be used to accelerate its omnichannel expansion across digital and offline formats, including its D2C platform, e-commerce and quick commerce marketplaces, Exclusive Brand Outlets (EBOs), HORECA partnerships, and curated retail presence, RAS Luxury Skincare said in a press release. Founded in 2021 by Shubhika, Suramya and Sangeeta Jain, RAS Luxury Skincare operates a vertically integrated model spanning the cultivation of botanicals on family-owned farms, in-house R&D, and small-batch manufacturing. The company offers products such as face elixirs, serums and moisturisers, formulated with essential oils and plant-based actives. RAS Luxury Skincare plans to invest in brand-building and marketing initiatives to deepen consumer engagement in the premium luxury segment. It also plans to expand its team across key functions, including product development, marketing and operations, to support its next phase of growth. RAS claims to have demonstrated strong growth momentum, with a three-year revenue CAGR of approximately 75%, an ARR of about Rs 100 crore, and high gross margins. The company has a consumer base exceeding 5,00,000 unique customers and a strong multi-channel presence spanning its D2C platform, e-commerce and quick commerce marketplaces, and premium offline retail. Disclaimer: Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investors here.

Neuroscience startup BrainSight AI raises $5 Mn

EntrackrEntrackr · 1y ago
Neuroscience startup BrainSight AI raises $5 Mn
Medial

Snippets Neuroscience startup BrainSight AI raises $5 Mn Deep-tech neuroscience startup BrainSight AI has raised $5 million in a pre-Series A funding round led by IAN Alpha Fund, along with participation from IvyCap Ventures, Silver Needle, and its existing investors. The fresh funds will be utilized to expand its presence in India, increasing reach in Tier I and Tier II cities, making a foray into Africa, Southeast Asia, the US, and allied markets, and enhancing R&D capabilities, BrainSight said in a press release. Co-founded in 2019 by Laina Emmanuel and Rimjhim Agrawal, BrainSight AI aims to enable greater precision in the diagnosis and treatment planning of neuro-oncological and neuropsychiatric disorders. The platform combines artificial intelligence and neuroscience to enable precision in neurological and psychiatric investigations for accelerated patient outcomes. According to BrainSight, its platform products include Voxelbox, which provides clinicians with access to an fMRI processing engine and machine-learning models; and Snowdrop, a patient care app that enables compliance with treatment schedules and builds patient profiles. Currently, BrainSight AI asserts that it collaborates with over 40 leading hospitals across India, particularly in neurosurgery and radiology departments, focusing on brain tumor cases. The company is now expanding its solutions to neurological and psychiatric disorders, paving the way for a more holistic approach to brain care. BrainSight AI helps to understand how the physiology of the brain correlates to its functions by mapping macro-scale neural connections in the brain to enable precise diagnosis and prognosis of neuro-oncological and neuropsychiatric disorders.

Download the medial app to read full posts, comements and news.